New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1 alpha signaling is essential for promoting adaptation and survival to hypoxia

Dan Cojocari, Ravi N. Vellanki, Brandon Sit, David Uehling, Marianne Koritzinsky, Bradly G. Wouters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)541-547
JournalRadiotherapy and Oncology
Issue number3
Publication statusPublished - Sep 2013


  • UPR
  • Hypoxia
  • Small-molecule inhibitors
  • PERK
  • IRE1 alpha

Cite this